CochLear EBITDA Margin 2023-2024 | CHEOY
CochLear EBITDA Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $11.341B | $1.488B |
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. |